Your browser doesn't support javascript.
loading
Treatment with Sotrovimab and Casirivimab/Imdevimab Enhances Serum SARS-CoV-2 S Antibody Levels in Patients Infected with the SARS-CoV-2 Delta, Omicron BA.1, and BA.5 Variants.
Fujimoto, Kana; Mutsuo, Satoru; Yasuda, Yuto; Arasawa, Soichi; Tashima, Noriyuki; Iwashima, Daisuke; Takahashi, Ken-Ichi.
Afiliação
  • Fujimoto K; Department of Respiratory Medicine, Kishiwada City Hospital, 1001 Gakuhara-cho, Kishiwada-shi 596-8501, Osaka, Japan.
  • Mutsuo S; Department of Central Clinical Laboratory, Kishiwada City Hospital, 1001 Gakuhara-cho, Kishiwada-shi 59-8501, Osaka, Japan.
  • Yasuda Y; Department of Respiratory Medicine, Kishiwada City Hospital, 1001 Gakuhara-cho, Kishiwada-shi 596-8501, Osaka, Japan.
  • Arasawa S; Department of Gastroenterology, Kishiwada City Hospital, 1001 Gakuhara-cho, Kishiwada-shi 596-8501, Osaka, Japan.
  • Tashima N; Department of Respiratory Medicine, Kishiwada City Hospital, 1001 Gakuhara-cho, Kishiwada-shi 596-8501, Osaka, Japan.
  • Iwashima D; Department of Respiratory Medicine, Kishiwada City Hospital, 1001 Gakuhara-cho, Kishiwada-shi 596-8501, Osaka, Japan.
  • Takahashi KI; Department of Respiratory Medicine, Kishiwada City Hospital, 1001 Gakuhara-cho, Kishiwada-shi 596-8501, Osaka, Japan.
Infect Dis Rep ; 14(6): 996-1003, 2022 Dec 09.
Article em En | MEDLINE | ID: mdl-36547245

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Infect Dis Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Infect Dis Rep Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Japão